Cytogenetic genotype-phenotype studies: Improving genotyping, phenotyping and data storage

Cytogenetic and Genome Research

Volumn 115, Issue 3-4, 2006, Pages 231-239

  Feenstra, I ^a   Brunner, H G ^a   Van Ravenswaaij, C M A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAT CRY SYNDROME; CHROMOSOME 16P; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 4P; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 18Q SYNDROME; CHROMOSOME DELETION 1P36 SYNDROME; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER PROGRAM; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIGEORGE SYNDROME; GENE AMPLIFICATION; GENE FUNCTION; GENE LOCUS; GENETIC DATABASE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFORMATION PROCESSING; KARYOTYPING; MENTAL DEFICIENCY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NOMENCLATURE; NUMERICAL CHROMOSOME ABERRATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RUBINSTEIN SYNDROME; SMITH MAGENIS SYNDROME; SOTOS SYNDROME; WOLF HIRSCHHORN SYNDROME;

CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME DISORDERS; COMPUTATIONAL BIOLOGY; CYTOGENETIC ANALYSIS; DATA INTERPRETATION, STATISTICAL; DATABASES, GENETIC; GENE DELETION; GENETIC TECHNIQUES; GENOTYPE; HUMANS; PHENOTYPE; SYNDROME;

EID: 33751516684     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095919     Document Type: Review

References (92)

1. Allanson JE: Objective techniques for craniofacial assessment: what are the choices? Am J Med Genet 70:1-5 (1997).
2. Altherr MR, Bengtsson U, et al: Molecular confirmation of Wolf-Hirschhorn syndrome with a subtle translocation of chromosome 4. Am J Hum Genet 49:1235-1242 (1991).
3. Barrett MT, Scheffer A, et al: Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci USA 101:17765-17770 (2004).
4. Bi W, Saifi GM, et al: Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome. Hum Genet 115:515-524 (2004).
5. Biesecker LG: Mapping phenotypes to language: a proposal to organize and standardize the clinical descriptions of malformations. Clin Genet 68:320-326 (2005).
6. Bonaglia MC, Giorda R, et al: Disruption of the Pro-SAP2 gene in a t(12; 22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet 69:261-268 (2001).
7. Bonaglia MC, Giorda R, et al: Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet 43:822-828 (2006).
8. Brewer C, Holloway S, et al: A chromosomal deletion map of human malformations. Am J Hum Genet 63:1153-1159 (1998).
9. Brewer C, Holloway S, et al: A chromosomal duplication map of malformations: regions of suspected haplo- and triplolethality - and tolerance of segmental aneuploidy-in humans. Am J Hum Genet 64:1702-1708 (1999).
10. Brown S, Russo J, et al: The 13q- syndrome: the molecular definition of a critical deletion region in band 13q32. Am J Hum Genet 57:859-866 (1995).
11. Brown SA, Warburton D, et al: Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired. Nat Genet 20:180-183 (1998).
12. Church DM, Bengtsson U, et al: Molecular definition of deletions of different segments of distal 5p that result in distinct phenotypic features. Am J Hum Genet 56:1162-1172 (1995).
13. Cody JD, Ghidoni PD, et al: Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18q. Am J Med Genet 85:455-462 (1999).
14. De Grouchy J, Royer P, et al: Partial deletion of the long arms of the chromosome 18. Pathol Biol (Paris) 12:579-582 (1964).
15. de Vries BB, Pfundt R, et al: Diagnostic genome profiling in mental retardation. Am J Hum Genet 77:606-616 (2005).
16. DiLiberti JH, Olson DP: Photogrammetric evaluation in clinical genetics: theoretical considerations and experimental results. Am J Med Genet 39:161-166 (1991).
17. Estabrooks LL, Rao KW, et al: Preliminary phenotypic map of chromosome 4p16 based on 4p deletions. Am J Med Genet 57:581-586 (1995).
18. Feenstra I, Fang J, et al: European Cytogeneticists Association Register of Unbalanced Chromosome Aberrations (ECARUCA); An online database for rare chromosome abnormalities. Eur J Med Genet 49:279-291 (2006).
19. Freimer N, Sabatti C: The human phenome project. Nat Genet 34:15-21 (2003).
20. Garn SM, Smith BH, et al: Applications of pattern profile analysis to malformations of the head and face. Radiology 150:683-690 (1984).
21. Garn SM, Lavelle M, et al: Quantification of dysmorphogenesis: pattern variability index, sigma z. AJR Am J Roentgenol 144:365-369 (1985).
22. Gersh M, Goodart SA, et al: Evidence for a distinct region causing a cat-like cry in patients with 5p deletions. Am J Hum Genet 56:1404-1410 (1995).
23. Girirajan S, Elsas LJ 2nd, et al: RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. J Med Genet 42:820-828 (2005).
24. Greenberg F, Guzzetta V, et al: Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2). Am J Hum Genet 49:1207-1218 (1991).
25. Hall JG: A clinician's plea. Nat Genet 33:440-442 (2003).
26. Hammond P, Hutton TJ, et al: Discriminating power of localized three-dimensional facial morphology. Am J Hum Genet 77:999-1010 (2005).
27. Heilstedt HA, Ballif BC, et al: Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet 72:1200-1212 (2003).
28. Hirschhorn K, Cooper HL, et al: Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion. Humangenetik 1:479-482 (1965).
29. Jerome LA, Papaioannou VE: DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1 . Nat Genet 27:286-291 (2001).
30. Johnson VP, Altherr MR, et al: FISH detection of Wolf-Hirschhorn syndrome: exclusion of D4F26 as critical site. Am J Med Genet 52:70-74 (1994).
31. Kleefstra T, Smidt M, et al: Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J Med Genet 42:299-306 (2005).
32. Kleefstra T, Brunner HG, et al: Loss of function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet 79:370-377 (2006).
33. Kline AD, White ME, et al: Molecular analysis of the 18q- syndrome - and correlation with phenotype. Am J Hum Genet 52:895-906 (1993).
34. Koolen DA, Nillesen WM, et al: Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA). J Med Genet 41:892-899 (2004).
35. Koolen DA, Reardon W, et al: Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation. Eur J Hum Genet 13:1019-1024 (2005).
36. Koolen DA, Herbergs J, et al: Holoprosencephaly and preaxial polydactyly associated with a 1.24 Mb duplication encompassing FBXW11 at 5q35.1. J Hum Genet 51:721-726 (2006).
37. Kreuz FR, Wittwer BH: Del(2q)-cause of the wrinkly skin syndrome? Clin Genet 43:132-138 (1993).
38. Kurotaki N, Imaizumi K, et al: Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 30:365-366 (2002).
39. Lejeune J, Lafourcade J, et al: 3 Cases of partial deletion of the short arm of chromosome 5. C R Hebd Seances Acad Sci 257:3098-3102 (1963).
40. Loos HS, Wieczorek D, et al: Computer-based recognition of dysmorphic faces. Eur J Hum Genet 11:555-560 (2003).
41. Mainardi PC, Perfumo C, et al: Clinical and molecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlation. J Med Genet 38:151-158 (2001).
42. Merks JH, van Karnebeek CD, et al: Phenotypic abnormalities: terminology and classification. Am J Med Genet A 123:211-230 (2003).
43. Miller DA, Warburton D, et al: Clustering in deleted short-arm length among 25 cases with a Bp-chromosome. Cytogenetics 8:109-116 (1969).
44. Miyazaki K, Yamanaka T, et al: Interstitial deletion 2q32.1 ] q34 in a child with half normal activity of ribulose 5-phosphate 3-epimerase (RPE). J Med Genet 25:850-851 (1988).
45. Muenke M, Gurrieri F, et al: Linkage of a human brain malformation, familial holoprosencephaly, to chromosome 7 and evidence for genetic heterogeneity. Proc Natl Acad Sci USA 91:8102-8106 (1994).
46. Niebuhr E: The Cri du Chat syndrome: epidemiology, cytogenetics, and clinical features. Hum Genet 44:227-275 (1978a).
47. Niebuhr E: Cytologic observations in 35 individuals with a 5p- karyotype. Hum Genet 42:143-156 (1978b).
48. Overhauser J, Huang X, et al: Molecular and phenotypic mapping of the short arm of chromosome 5: sublocalization of the critical region for the cri-du-chat syndrome. Hum Mol Genet 3:247-252 (1994).
49. Overhauser J, Mitchell HF, et al: Physical mapping of the holoprosencephaly critical region in 18p11.3. Am J Hum Genet 57:1080-1085 (1995).
50. Palmer CG, Heerema N, et al: Deletions in chromosome 2 and fragile sites. Am J Med Genet 36:214-218 (1990).
51. Petrij F, Giles RH, et al: Rubinstein-Taybi syndrome caused by mutations in the transcriptional coactivator CBP. Nature 376:348-351 (1995).
52. Pinkel D, Segraves R, et al: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211 (1998).
53. Prasad C, Prasad AN, et al: Genetic evaluation of pervasive developmental disorders: the terminal 22q13 deletion syndrome may represent a recognizable phenotype. Clin Genet 57:103-109 (2000).
54. Rauch A, Beese M, et al: A novel 5q35.3 subtelomeric deletion syndrome. Am J Med Genet A 121:1-8 (2003).
55. Rauch A, Zink S, et al: Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2. J Med Genet 42:871-876 (2005).
56. Redon R, Rio M, et al: Tiling path resolution mapping of constitutional 1p36 deletions by array-CGH: contiguous gene deletion or 'deletion with positional effect' syndrome? J Med Genet 42:166-171 (2005).
57. Richtsmeier JT: Comparative study of normal, Crouzon, and Apert craniofacial morphology using finite element scaling analysis. Am J Phys Anthropol 74:473-493 (1987).
58. Rodriguez L, Zollino M, et al: The new Wolf-Hirschhorn syndrome critical region (WHSCR-2): a description of a second case. Am J Med Genet A 136:175-178 (2005).
59. Roelfsema JH, White SJ, et al: Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 76:572-580 (2005).
60. Schell U, Wienberg J, et al: Molecular characterization of breakpoints in patients with holoprosencephaly and definition of the HPE2 critical region 2p21. Hum Mol Genet 5:223-229 (1996).
61. Schinzel A: Zurich Cytogenetics Database (1994).
62. Schinzel A: Catalogue of Unbalanced Chromosome Aberrations in Man. (De Gruyter, Berlin 2001).
63. Schouten JP, McElgunn CJ, et al: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57 (2002).
64. Shaffer LG, Lupski JR: Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu Rev Genet 34:297-329 (2000).
65. Shaner DJ, Peterson AE, et al: Soft tissue facial resemblance in families and syndrome-affected individuals. Am J Med Genet 102:330-341 (2001).
66. Shapira SK, McCaskill C, et al: Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet 61:642-650 (1997).
67. Slager RE, Newton TL, et al: Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet 33:466-468 (2003).
68. Slater HR, Bailey DK, et al: High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. Am J Hum Genet 77:709-726 (2005).
69. Smith AC, Dykens E, et al: Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2). Am J Med Genet 81:179-185 (1998).
70. Speicher MR, Carter NP: The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 6:782-792 (2005).
71. Stec I, Wright TJ, et al: WHSC1 , a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4; 14) multiple myeloma. Hum Mol Genet 7:1071-1082 (1998).
72. Stewart DR, Huang A, et al: Subtelomeric deletions of chromosome 9q: a novel microdeletion syndrome. Am J Med Genet A 128:340-351 (2004).
73. Tassabehji M, Hammond P, et al: GTF2IRD1 in craniofacial development of humans and mice. Science 310:1184-1187 (2005).
74. Van Buggenhout G, Melotte C, et al: Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map. J Med Genet 41:691-698 (2004).
75. Van Buggenhout G, Van Ravenswaaij-Arts C, et al: The del(2)(q32.2q33) deletion syndrome defined by clinical and molecular characterization of four patients. Eur J Med Genet 48:276-289 (2005).
76. Veltman JA, Jonkers Y, et al: Definition of a critical region on chromosome 18 for congenital aural atresia by array CGH. Am J Hum Genet 72:1578-1584 (2003).
77. Vissers LE, Veltman JA, et al: Identification of disease genes by whole genome CGH arrays. Hum Mol Genet 14 Spec No. 2:R215-223 (2005).
78. Vlangos CN, Yim DK, et al: Refinement of the Smith-Magenis syndrome critical region to approximately 950 kb and assessment of 17p11.2 deletions. Are all deletions created equally? Mol Genet Metab 79:134-141 (2003).
79. Vogels A, Haegeman J, et al: Pierre-Robin sequence and severe mental retardation with chaotic behaviour associated with a small interstitial deletion in the long arm of chromosome 2 (del(2)(q331q333)). Genet Couns 8:249-252 (1997).
80. Wallis DE, Roessler E, et al: Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly. Nat Genet 22:196-198 (1999).
81. Wilson HL, Wong AC, et al: Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 40:575-584 (2003).
82. Wilson MG, Towner JW, et al: Genetic and clinical studies in 13 patients with the Wolf-Hirschhorn syndrome [del(4p)]. Hum Genet 59:297-307 (1981).
83. Winter RM: What's in a face? Nat Genet 12:124-129 (1996).
84. Wolf U, Reinwein H, et al: Deficiency on the short arms of a chromosome No. 4. Humangenetik 1:397-413 (1965).
85. Wright TJ, Ricke DO, et al: A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. Hum Mol Genet 6:317-324 (1997).
86. Wright TJ, Costa JL, et al: Comparative analysis of a novel gene from the Wolf-Hirschhorn/Pitt-Rogers-Danks syndrome critical region. Genomics 59:203-212 (1999).
87. Wu YQ, Heilstedt HA, et al: Molecular refinement of the 1p36 deletion syndrome reveals size diversity and a preponderance of maternally derived deletions. Hum Mol Genet 8:313-321 (1999).
88. Yagi H, Furutani Y, et al: Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366-1373 (2003).
89. Yu W, Ballif BC, et al: Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions. Hum Mol Genet 12:2145-2152 (2003).
90. Zhang X, Snijders A, et al: High-resolution mapping of genotype-phenotype relationships in Cri du Chat syndrome using array comparative genomic hybridization. Am J Hum Genet 76:312-326 (2005).
91. Zollino M, Di Stefano C, et al: Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome. Am J Med Genet 94:254-261 (2000).
92. Zollino M, Lecce R, et al: Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. Am J Hum Genet 72:590-597 (2003).